UnitedHealth Group Incorporated
Stock Forecast, Prediction & Price Target
UnitedHealth Group Incorporated (UNH) stock Price Target by analysts
UnitedHealth Group Incorporated (UNH) stock Price Target by analysts
Average Price Target
$633.5
Potential upside: 110.39%
UnitedHealth Group Incorporated price prediction
What is UnitedHealth Group Incorporated stock analysts` prediction?
UnitedHealth Group Incorporated stock forecast: Based on 6 Wall Street analysts` predicted price targets for UnitedHealth Group Incorporated in the last 3 months, the avarage price target is $633.5, with a high forecast of $NaN. The average price target represents a 110.39% change from the last price of $301.1.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
UnitedHealth Group Incorporated stock Price Target by analysts
Full breakdown of analysts given UnitedHealth Group Incorporated price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Windley Jefferies | 25% 1/4 | 9 months ago | $635 110.89% upside | $549.53 | StreetInsider | Previous targets (3) |
David Windley Jefferies | 25% 1/4 | 11 months ago | $643 113.55% upside | $556.29 | StreetInsider | Previous targets (3) |
Matthew Gillmor KeyBanc | 0% 0/2 | 11 months ago | $650 115.87% upside | $569.66 | StreetInsider | Previous targets (1) |
George Hill Deutsche Bank | 0% 0/2 | 11 months ago | $595 97.60% upside | $556.29 | StreetInsider | Previous targets (1) |
Joanna Gajuk Bank of America Securities | 0% 0/1 | 11 months ago | $650 115.87% upside | $556.29 | TheFly | Previous targets (0) |
Ben Hendrix RBC Capital | 0% 0/4 | 11 months ago | $595 97.60% upside | $556.29 | StreetInsider | Previous targets (3) |
David MacDonald Truist Financial | 0% 0/2 | 11 months ago | $625 107.57% upside | $556.29 | StreetInsider | Previous targets (1) |
Matthew Gillmor KeyBanc | 0% 0/2 | 11 months ago | $675 124.17% upside | $597.7 | TheFly | Previous targets (1) |
David Toung Argus Research | 50% 1/2 | about 1 year ago | $600 99.26% upside | $565.78 | TheFly | Previous targets (1) |
Scott Fidel Stephens | 50% 1/2 | about 1 year ago | $600 99.26% upside | $548.87 | TheFly | Previous targets (1) |
David Windley Jefferies | 25% 1/4 | about 1 year ago | $647 114.87% upside | $573.28 | StreetInsider | Previous targets (3) |
David MacDonald Truist Financial | 0% 0/2 | about 1 year ago | $640 112.55% upside | $548.87 | TheFly | Previous targets (1) |
Sidharth Sahoo HSBC | 0% 0/1 | over 1 year ago | $580 92.62% upside | $503.12 | StreetInsider | Previous targets (0) |
George Hill Deutsche Bank | 0% 0/2 | over 1 year ago | $562 86.64% upside | $493.18 | StreetInsider | Previous targets (1) |
Stephen Baxter Wells Fargo | 0% 0/2 | over 1 year ago | $525 74.36% upside | $483.16 | StreetInsider | Previous targets (1) |
Jessica Tassan Piper Sandler | 0% 0/2 | over 1 year ago | $571 89.63% upside | $468.89 | StreetInsider | Previous targets (1) |
Ben Hendrix RBC Capital | 0% 0/4 | over 1 year ago | $555 84.32% upside | $468.89 | StreetInsider | Previous targets (3) |
Jessica Tassan Piper Sandler | 0% 0/2 | over 1 year ago | $566 87.97% upside | $450.05 | StreetInsider | Previous targets (1) |
Erin Wright Morgan Stanley | 0% 0/1 | over 1 year ago | $584 93.95% upside | $455.38 | StreetInsider | Previous targets (0) |
Rajesh Kumar HSBC | 100% 1/1 | over 1 year ago | $460 52.77% upside | $454.65 | StreetInsider | Previous targets (0) |
Michael Wiederhorn Oppenheimer | 50% 1/2 | about 2 years ago | $610 102.59% upside | $483.47 | Benzinga | Previous targets (1) |
Strong Buy Raymond James | 0% 0/1 | over 2 years ago | $630 109.23% upside | $510.86 | Benzinga | Previous targets (0) |
Unknown Credit Suisse | N/A | almost 3 years ago | $610 102.59% upside | $542.48 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | almost 3 years ago | $587 94.95% upside | $525.18 | Benzinga | N/A |
Unknown Raymond James | N/A | almost 3 years ago | $635 110.89% upside | $512.08 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | about 3 years ago | $569 88.97% upside | $525.08 | Benzinga | N/A |
Unknown Mizuho Securities | N/A | about 3 years ago | $600 99.26% upside | $537.43 | Benzinga | N/A |
Kavin Caliendo UBS | 0% 0/1 | about 3 years ago | $570 89.30% upside | $542.52 | Pulse 2.0 | Previous targets (0) |
Unknown Argus Research | N/A | about 3 years ago | $650 115.87% upside | $528.49 | Benzinga | N/A |
Unknown UBS | N/A | about 3 years ago | $570 89.30% upside | $519.47 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | about 3 years ago | $556 84.65% upside | $528.98 | Benzinga | N/A |
Unknown Credit Suisse | N/A | about 3 years ago | $579 92.29% upside | $525.87 | Benzinga | N/A |
Unknown Oppenheimer | N/A | about 3 years ago | $610 102.59% upside | $525.36 | Benzinga | N/A |
Unknown Leerink Partners | N/A | about 3 years ago | $625 107.57% upside | $525.3 | Benzinga | N/A |
Stephen Baxter Wells Fargo | 0% 0/2 | over 3 years ago | $612 103.25% upside | $507.11 | Pulse 2.0 | Previous targets (1) |
Matt Borsch BMO Capital | 0% 0/1 | over 3 years ago | $600 99.26% upside | $517.57 | Pulse 2.0 | Previous targets (0) |
Unknown Wells Fargo | N/A | over 3 years ago | $613 103.58% upside | $537.44 | Benzinga | N/A |
Ben Hendrix RBC Capital | 0% 0/4 | over 3 years ago | $588 95.28% upside | $537.7 | Pulse 2.0 | Previous targets (3) |
Ann Hynes Mizuho Securities | 100% 1/1 | over 3 years ago | $550 82.66% upside | $534.82 | TipRanks Contributor | Previous targets (0) |
Kevin Caliendo UBS | 100% 2/2 | over 3 years ago | $545 81.00% upside | $537 | StreetInsider | Previous targets (1) |
David S Macdonald Truist Financial | 0% 0/1 | over 3 years ago | $610 102.59% upside | $536.95 | TheFly | Previous targets (0) |
David Windley Jefferies | 25% 1/4 | over 3 years ago | $485 61.07% upside | $531.75 | StreetInsider | Previous targets (3) |
Steve Valiquette Barclays | 0% 0/1 | over 3 years ago | $565 87.64% upside | $512.59 | Pulse 2.0 | Previous targets (0) |
Whit Mayo Leerink Partners | 100% 1/1 | over 3 years ago | $550 82.66% upside | $466.06 | Pulse 2.0 | Previous targets (0) |
Kevin Caliendo UBS | 100% 2/2 | over 3 years ago | $468 55.43% upside | $461.63 | StreetInsider | Previous targets (1) |
Michael Newshel Evercore ISI | 100% 1/1 | over 3 years ago | $480 59.41% upside | $461.16 | TipRanks Contributor | Previous targets (0) |
Ben Hendrix RBC Capital | 0% 0/4 | over 3 years ago | $563 86.98% upside | $461.16 | TipRanks Contributor | Previous targets (3) |
Kevin Fischbeck Bank of America Securities | 0% 0/1 | over 3 years ago | $574.2 90.70% upside | $461.16 | TipRanks Contributor | Previous targets (0) |
Joseph France Seaport Global | 100% 1/1 | over 3 years ago | $525 74.36% upside | $467.31 | StreetInsider | Previous targets (0) |
Lance Wilkes Bernstein | 0% 0/1 | over 3 years ago | $564 87.31% upside | $467.62 | TheFly | Previous targets (0) |
UnitedHealth Group Incorporated Financial Estimates
UnitedHealth Group Incorporated Revenue Estimates
UnitedHealth Group Incorporated EBITDA Estimates
UnitedHealth Group Incorporated Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $285.27B N/A | $322.13B 12.92% | $367.53B 14.09% | Avg: $429.18B Low: $417.76B High: $439.22B avg. 16.77% | Avg: $461.03B Low: $452.97B High: $468.09B avg. 7.42% | Avg: $502.67B Low: $493.89B High: $510.37B avg. 9.03% | Avg: $567.62B Low: $557.70B High: $576.31B avg. 12.92% |
Net Income
% change YoY
| $17.28B N/A | $20.12B 16.40% | $22.38B 11.23% | Avg: $26.98B Low: $24.74B High: $29.59B avg. 20.55% | Avg: $30.05B Low: $28.14B High: $33.44B avg. 11.38% | Avg: $36.42B Low: $35.60B High: $37.15B avg. 21.21% | Avg: $43.27B Low: $42.29B High: $44.14B avg. 18.80% |
EBITDA
% change YoY
| $24.74B N/A | $29.80B 20.42% | $32.51B 9.09% | Avg: $39.10B Low: $38.06B High: $40.01B avg. 20.24% | Avg: $42.00B Low: $41.26B High: $42.64B avg. 7.42% | Avg: $45.79B Low: $44.99B High: $46.49B avg. 9.03% | Avg: $51.71B Low: $50.80B High: $52.50B avg. 12.92% |
EPS
% change YoY
| $18.33 N/A | $21.47 17.13% | $24.12 12.34% | Avg: $29.62 Low: $26.38 High: $31.55 avg. 22.81% | Avg: $33.55 Low: $30.01 High: $35.65 avg. 13.24% | Avg: $38.84 Low: $37.95 High: $39.61 avg. 15.77% | Avg: $46.14 Low: $45.09 High: $47.06 avg. 18.80% |
Operating Expenses
% change YoY
| $45.68B N/A | $51.18B 12.03% | $54.51B 6.50% | Avg: $64.73B Low: $63.01B High: $66.25B avg. 18.76% | Avg: $69.54B Low: $68.32B High: $70.60B avg. 7.42% | Avg: $75.82B Low: $74.49B High: $76.98B avg. 9.03% | Avg: $85.62B Low: $84.12B High: $86.93B avg. 12.92% |
FAQ
What is UnitedHealth Group Incorporated stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 17.98% in 2025-2028.
We have gathered data from 19 analysts. Their low estimate is 24.74B, average is 26.98B and high is 29.59B.
What is UnitedHealth Group Incorporated stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 11.53% in 2025-2028.
We have gathered data from 19 analysts. Their low revenue estimate is $417.76B, average is $429.18B and high is $439.22B.
What is UnitedHealth Group Incorporated stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 17.65% in 2025-2028.
We have gathered data from 19 analysts. Their low earnings per share estimate is $26.38, average is $29.62 and high is $31.54.
What is the best performing analyst?
In the last twelve months 6 analysts have been covering UnitedHealth Group Incorporated stock. The most successful analyst is David Windley whose win rate is 25%. He has correctly predicted 1/4 price targets.